ReviewHuman genetics2009
Genomics and policymaking: from static models to complex systems?
Review in Human genetics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Governing the research-care divide in clinical biobanking: Dutch perspectives.Life sciences, society and policy · 2015Review
- Power to the people: a wiki-governance model for biobanks.Genome biology · 2012Article
- Designing a post-genomics knowledge ecosystem to translate pharmacogenomics into public health action.Genome medicine · 2012Article
- Reflexive governance in biobanking: on the value of policy led approaches and the need to recognise the limits of law.Human genetics · 2011Article
- Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value.Current pharmacogenomics and personalized medicine · 2010Article
- Retrospective access to data: the ENGAGE consent experience.European journal of human genetics : EJHG · 2010Article
- Consent to 'personal' genomics and privacy. Direct-to-consumer genetic tests and population genome research challenge traditional notions of privacy and consent.EMBO reports · 2010Article
- Meeting the governance challenges of next-generation biorepository research.Science translational medicine · 2010Article
- Personalized Medicine Beyond Genomics: New Technologies, Global Health Diplomacy and Anticipatory Governance.Current pharmacogenomics and personalized medicine · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the 20 years following the launching of the Human Genome Project, socio-ethical and legal responses to the policy issues raised have varied across jurisdictions. There seems, however, to be a move away from the more static, classical responses that characterized the first decade to a more epigenetic and complex one. The latter policy approach better reflects the dynamic nature of the science itself.
Indexed as
Identifiers
19252928What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.